These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 23875476)

  • 1. [Cancer targeted therapy and resistance signals].
    Yano S
    Seikagaku; 2013 Jun; 85(6):475-83. PubMed ID: 23875476
    [No Abstract]   [Full Text] [Related]  

  • 2. Mechanisms of acquired resistance to targeted cancer therapies.
    Lackner MR; Wilson TR; Settleman J
    Future Oncol; 2012 Aug; 8(8):999-1014. PubMed ID: 22894672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug resistance, epigenetics, and tumor cell heterogeneity.
    Hoey T
    Sci Transl Med; 2010 Apr; 2(28):28ps19. PubMed ID: 20410528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic mechanisms in tumorigenesis, tumor cell heterogeneity and drug resistance.
    Wilting RH; Dannenberg JH
    Drug Resist Updat; 2012; 15(1-2):21-38. PubMed ID: 22356866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatic alterations as the basis for resistance to targeted therapies.
    Blair BG; Bardelli A; Park BH
    J Pathol; 2014 Jan; 232(2):244-54. PubMed ID: 24114654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The dynamic control of signal transduction networks in cancer cells.
    Kolch W; Halasz M; Granovskaya M; Kholodenko BN
    Nat Rev Cancer; 2015 Sep; 15(9):515-27. PubMed ID: 26289315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New hopes in the fight against cancer: a special issue on targeted anti-cancer drug discovery and cell signaling.
    Cheng X
    Acta Biochim Biophys Sin (Shanghai); 2016 Jan; 48(1):1-2. PubMed ID: 26578705
    [No Abstract]   [Full Text] [Related]  

  • 8. Snapshot: genetic mouse models of cancer.
    Zender L; Zuber J; Lowe SW
    Cell; 2007 May; 129(4):838. PubMed ID: 17512415
    [No Abstract]   [Full Text] [Related]  

  • 9. Anticipating designer drug-resistant cancer cells.
    Frangione ML; Lockhart JH; Morton DT; Pava LM; Blanck G
    Drug Discov Today; 2015 Jul; 20(7):790-3. PubMed ID: 25697478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer cells acquire resistance to anticancer drugs: an update.
    Lu HP; Chao CC
    Biomed J; 2012; 35(6):464-72. PubMed ID: 23442359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer therapy: an evolved approach.
    Willyard C
    Nature; 2016 Apr; 532(7598):166-8. PubMed ID: 27075079
    [No Abstract]   [Full Text] [Related]  

  • 12. Editorial overview: cancer: from target discovery to targeted therapy: the risky business of target validation.
    Cruzalegui F
    Curr Opin Pharmacol; 2014 Aug; 17():iv-vi. PubMed ID: 25220882
    [No Abstract]   [Full Text] [Related]  

  • 13. Farnesyl transferase inhibitors.
    Li T; Sparano JA
    Cancer Invest; 2008 Aug; 26(7):653-61. PubMed ID: 18665473
    [No Abstract]   [Full Text] [Related]  

  • 14. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
    Shapira A; Livney YD; Broxterman HJ; Assaraf YG
    Drug Resist Updat; 2011 Jun; 14(3):150-63. PubMed ID: 21330184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opening a Pandora's (F)-box in cancer.
    Azmi AS
    Semin Cancer Biol; 2016 Feb; 36():1-2. PubMed ID: 26706999
    [No Abstract]   [Full Text] [Related]  

  • 16. Resistance to mTORC1 Inhibitors in Cancer Therapy: From Kinase Mutations to Intratumoral Heterogeneity of Kinase Activity.
    Faes S; Demartines N; Dormond O
    Oxid Med Cell Longev; 2017; 2017():1726078. PubMed ID: 28280521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The antitumor effects of geraniol: Modulation of cancer hallmark pathways (Review).
    Cho M; So I; Chun JN; Jeon JH
    Int J Oncol; 2016 May; 48(5):1772-82. PubMed ID: 26983575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mapping the Pathways of Resistance to Targeted Therapies.
    Wood KC
    Cancer Res; 2015 Oct; 75(20):4247-51. PubMed ID: 26392071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting autophagy to overcome drug resistance in cancer therapy.
    Kumar A; Singh UK; Chaudhary A
    Future Med Chem; 2015 Aug; 7(12):1535-42. PubMed ID: 26334206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Basic cancer research is essential for the success of personalised medicine.
    Yarden Y; Caldas C;
    Eur J Cancer; 2013 Aug; 49(12):2619-20. PubMed ID: 23726268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.